We offer 2 medications that mimic the GLP-1 in Kansas City: semaglutide and tirzepatide
Eftekhari, S., Montazeri, H., & Tarighi, P
This medication has shown remarkable potential in managing type 2 diabetes and supporting weight loss
consultant, speaker, advisor, or received research support from Aspire Bariatrics Inc., Eisai, Ethicon Endo-Surgery Inc., GlaxoSmithKline Consumer Healthcare LP, GI Dynamics, Novo Nordisk, Pfizer, Takeda Pharmaceuticals, Vivus Inc., Zafgen Inc
Data was self-reported by 7,520 surveyed NAD+ Injection customers, 4,330 surveyed B12 Injection customers, and 24,800 LDN customers who checked in with their provider between second and third check-in
This dual-action medication targets two metabolic hormones instead of one, which is clinically associated with superior efficacy and more significant weight loss outcomes for many patients